434 related articles for article (PubMed ID: 11816713)
1. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F
Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713
[TBL] [Abstract][Full Text] [Related]
2. A novel missense mutation shows that GPIbbeta has a dual role in controlling the processing and stability of the platelet GPIb-IX adhesion receptor.
Strassel C; Pasquet JM; Alessi MC; Juhan-Vague I; Chambost H; Combrié R; Nurden P; Bas MJ; De La Salle C; Cazenave JP; Lanza F; Nurden AT
Biochemistry; 2003 Apr; 42(15):4452-62. PubMed ID: 12693941
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
4. Role of the leucine-rich domain of platelet GPIbalpha in correct post-translational processing--the Nancy I Bernard-Soulier mutation expressed on CHO cells.
Ulsemer P; Lanza F; Baas MJ; Schwartz A; Ravanat C; Briquel ME; Cranmer S; Jackson S; Cazenave JP; de la Salle C
Thromb Haemost; 2000 Jul; 84(1):104-11. PubMed ID: 10928479
[TBL] [Abstract][Full Text] [Related]
5. Targeting platelet GPIbβ reduces platelet adhesion, GPIb signaling and thrombin generation and prevents arterial thrombosis.
Maurer E; Tang C; Schaff M; Bourdon C; Receveur N; Ravanat C; Eckly A; Hechler B; Gachet C; Lanza F; Mangin PH
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1221-9. PubMed ID: 23559635
[TBL] [Abstract][Full Text] [Related]
6. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
[TBL] [Abstract][Full Text] [Related]
7. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
8. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
[TBL] [Abstract][Full Text] [Related]
9. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
10. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation.
Hauert J; Fernandez-Carneado J; Michielin O; Mathieu S; Grell D; Schapira M; Spertini O; Mutter M; Tuchscherer G; Kovacsovics T
Chembiochem; 2004 Jun; 5(6):856-64. PubMed ID: 15174170
[TBL] [Abstract][Full Text] [Related]
11. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
[TBL] [Abstract][Full Text] [Related]
12. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein (GP) Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow. Importance of the GPib/actin-binding protein (ABP-280) interaction in maintaining adhesion under high shear.
Cranmer SL; Ulsemer P; Cooke BM; Salem HH; de la Salle C; Lanza F; Jackson SP
J Biol Chem; 1999 Mar; 274(10):6097-106. PubMed ID: 10037692
[TBL] [Abstract][Full Text] [Related]
14. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic analysis of a variant Bernard-Soulier syndrome due to compound heterozygosity for two novel glycoprotein Ibbeta mutations.
Kunishima S; Sako M; Yamazaki T; Hamaguchi M; Saito H
Eur J Haematol; 2006 Dec; 77(6):501-12. PubMed ID: 16978236
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of the platelet GPIb-IX complex by anti-GPIbβ antibodies.
Quach ME; Chen W; Wang Y; Deckmyn H; Lanza F; Nieswandt B; Li R
J Thromb Haemost; 2021 Aug; 19(8):2044-2055. PubMed ID: 33915031
[TBL] [Abstract][Full Text] [Related]
17. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
[TBL] [Abstract][Full Text] [Related]
18. Role of the intracellular domains of GPIb in controlling the adhesive properties of the platelet GPIb/V/IX complex.
Perrault C; Mangin P; Santer M; Baas MJ; Moog S; Cranmer SL; Pikovski I; Williamson D; Jackson SP; Cazenave JP; Lanza F
Blood; 2003 May; 101(9):3477-84. PubMed ID: 12522011
[TBL] [Abstract][Full Text] [Related]
19. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
Kasirer-Friede A; Frojmovic MM
Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
[TBL] [Abstract][Full Text] [Related]
20. Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer.
O'Brien JR; Etherington MD
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):453-61. PubMed ID: 9818994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
